Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD

NCT02461134 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Low recruitment

Conditions

Chronic Graft Versus Host Disease

Interventions

DRUG: Ponesimod

Sponsor

Actelion